Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11

• Yunfei Liao,
• Slim Sassi,
• Stefan Halvorsen,
• Yong Feng,
• Jacson Shen,
• Yan Gao,
• Gregory Cote,
• Edwin Choy,
• David Harmon,
• Henry Mankin,
• Francis Hornicek,
• Zhenfeng Duan

Affiliations

Yunfei Liao

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School

Slim Sassi

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School

Stefan Halvorsen

Center for Computational and Integrative Biology (CCIB), Massachusetts General Hospital

Yong Feng

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School

Jacson Shen

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School

Yan Gao

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School

Gregory Cote

Division of Hematology and Oncology, Massachusetts General Hospital and Harvard Medical School

Edwin Choy

Division of Hematology and Oncology, Massachusetts General Hospital and Harvard Medical School

David Harmon

Division of Hematology and Oncology, Massachusetts General Hospital and Harvard Medical School

Henry Mankin

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School

Francis Hornicek

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School

Zhenfeng Duan

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School